News

BioWorld: Fluorination Propels SciFluor into 'Billion-Dollar' Markets

26-Oct-2012

Fluorination Propels SciFluor Into ‘Billion-Dollar’ Markets 
By Marie Powers Staff Writer 

Nearly one in four marketed drugs contains the chemical element fluorine, including household names for vastly different indications such as Lipitor (atorvastatin, Pfizer Inc.), Cipro (ciprofloxacin, Bayer AG) and Prozac (fluoxetine, Eli Lilly and Co.) The reason? The carbon-fluorine bond, the strongest in organic chemistry, is widely used to block sites of metabolism and improve drug half-life. Using fluorine to modify the chemical structure of a drug has been demonstrated to improve potency, selectivity, tissue penetration, half-life and metabolic stability.

To read further please visit via subscription:

 

The Latest Press

16-Dec-2014

Startup Seamless Devices Launches from Prof. Peter Kinget’s Lab

Please view the full article at: http://engineering.columbia.edu/startup-seamless-devices-launches-prof-peter-kinget%E2%80%99s-lab Startup Seamless Devi..

03-Dec-2014

SciFluor Life Sciences Awarded U.S. Patent for Integrin αvβ3 Inhibitors

SciFluor Life Sciences Awarded U.S. Patent for Integrin αvβ3 Inhibitors Designed for the Topical Treatment of Retinal Disease • Patent-protected topical..

01-Dec-2014

Optio Labs Names Mobile Industry Veteran Gregg Smith as CEO

Optio Labs Names Mobile Industry Veteran Gregg Smith as Chief Executive Officer Boston and Nashville, Tenn. (Dec. 2, 2014) – Optio Labs, a developer of technolog..